These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20557135)

  • 21. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
    Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers.
    Karczmarski J; Rubel T; Mikula M; Wolski J; Rutkowski A; Zagorowicz E; Dadlez M; Ostrowski J
    Acta Biochim Pol; 2013; 60(3):417-25. PubMed ID: 24046818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of serological proteomic methods to find biomarkers associated with breast cancer.
    Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
    Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics.
    Drukier AK; Ossetrova N; Schors E; Krasik G; Grigoriev I; Koenig C; Sulkowski M; Holcman J; Brown LR; Tomaszewski JE; Schnall MD; Sainsbury R; Lokshin AE; Godovac-Zimmermann J
    J Proteome Res; 2006 Aug; 5(8):1906-15. PubMed ID: 16889412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery.
    Shi Q; Harris LN; Lu X; Li X; Hwang J; Gentleman R; Iglehart JD; Miron A
    J Proteome Res; 2006 Nov; 5(11):2947-55. PubMed ID: 17081046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
    Abd Hamid UM; Royle L; Saldova R; Radcliffe CM; Harvey DJ; Storr SJ; Pardo M; Antrobus R; Chapman CJ; Zitzmann N; Robertson JF; Dwek RA; Rudd PM
    Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry.
    Byun JA; Lee SH; Jung BH; Choi MH; Moon MH; Chung BC
    Biomed Chromatogr; 2008 Jan; 22(1):73-80. PubMed ID: 17668437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
    Caputo E; Lombardi ML; Luongo V; Moharram R; Tornatore P; Pirozzi G; Guardiola J; Martin BM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):59-66. PubMed ID: 15797521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
    Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
    Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
    Liu DH; Zhang LM; Feng WY
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
    Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
    Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
    Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
    J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
    Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.